Using Clonidine to Improve Leg Weakness in People With Heart Failure

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

People with heart failure often have weakness in their leg muscles. This study will determine whether the leg weakness is due to very high adrenaline levels and whether the medication clonidine can improve leg weakness.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Los Angeles
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Clonidine

Criteria

Inclusion Criteria:

• Heart failure

Exclusion Criteria:

• Currently on Coumadin therapy

• Experienced a heart attack in the 3 months before study entry

• Medically unable to receive clonidine

• Advanced kidney or liver disease